PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-799

  1. 9,839 Posts.
    lightbulb Created with Sketch. 1258
    If you get the chance ask your contact why they're deferring OA deal in key target markets - US and EU5?

    The basis of their logic will be quite telling I'd suggest


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.